Mark S. Smyth

2.0k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

Mark S. Smyth is a scholar working on Molecular Biology, Organic Chemistry and Hematology. According to data from OpenAlex, Mark S. Smyth has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Organic Chemistry and 7 papers in Hematology. Recurrent topics in Mark S. Smyth's work include Platelet Disorders and Treatments (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Chemical Synthesis and Analysis (5 papers). Mark S. Smyth is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Chemical Synthesis and Analysis (5 papers). Mark S. Smyth collaborates with scholars based in United States, Netherlands and Australia. Mark S. Smyth's co-authors include Terrence R. Burke, Peter P. Roller, Motoyoshi Nomizu, Akira Otaka, Arthur G. Schultz, Harry Ford, Akihisa Otaka, Francesco Parlati, Guy J. Laidig and Tina M. Woo and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Biochemistry.

In The Last Decade

Mark S. Smyth

32 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome

2007 542 citations Susan D. Demo, Christopher J. Kirk et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark S. Smyth United States	16	1.1k	686	332	292	209	33	1.6k
Hon‐Wah Man United States	17	784 0.7×	412 0.6×	277 0.8×	459 1.6×	38 0.2×	24	1.5k
Mikel P. Moyer United States	19	2.1k 1.8×	371 0.5×	193 0.6×	267 0.9×	43 0.2×	28	2.5k
Hiroshi Kosugi Japan	27	743 0.7×	799 1.2×	429 1.3×	313 1.1×	45 0.2×	112	2.3k
Guido Bold Switzerland	25	907 0.8×	758 1.1×	490 1.5×	131 0.4×	34 0.2×	46	1.8k
Giorgio Caravatti Switzerland	26	1.5k 1.3×	660 1.0×	713 2.1×	206 0.7×	45 0.2×	45	2.3k
M. V. Ramana Reddy United States	23	933 0.8×	733 1.1×	488 1.5×	305 1.0×	36 0.2×	80	2.1k
Jerauld S. Skotnicki United States	22	934 0.8×	530 0.8×	466 1.4×	107 0.4×	30 0.1×	51	1.7k
Semiramis Ayral‐Kaloustian United States	26	1.6k 1.4×	1.0k 1.5×	379 1.1×	68 0.2×	53 0.3×	58	2.5k
Siavosh Mahboobi Germany	26	1.0k 0.9×	858 1.3×	369 1.1×	183 0.6×	21 0.1×	76	1.8k
Juerg Zimmermann Switzerland	7	716 0.6×	581 0.8×	356 1.1×	309 1.1×	26 0.1×	10	1.6k

Countries citing papers authored by Mark S. Smyth

Since Specialization

Citations

This map shows the geographic impact of Mark S. Smyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Smyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Smyth more than expected).

Fields of papers citing papers by Mark S. Smyth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Smyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Smyth. The network helps show where Mark S. Smyth may publish in the future.

Co-authorship network of co-authors of Mark S. Smyth

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Smyth. A scholar is included among the top collaborators of Mark S. Smyth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Smyth. Mark S. Smyth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Smyth, Mark S., et al.. (2024). Operating in the context of evolving climate disclosure practices and frameworks. 64(2). S202–S205.

Demo, Susan D., Christopher J. Kirk, Monette Aujay, et al.. (2007). Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome. Cancer Research. 67(13). 6383–6391. 542 indexed citations breakdown →

Kirk, Christopher J., Mark K. Bennett, Tonia J. Buchholz, et al.. (2005). Pharmacokinetics, Pharmacodynamics and Anti-Tumor Efficacy of PR-171, a Novel Inhibitor of the 20S Proteasome.. Blood. 106(11). 609–609. 2 indexed citations

Mehrotra, Mukund M., Julie A. Heath, Jack W. Rose, et al.. (2002). Spirocyclic nonpeptide glycoprotein IIb–IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanes. Bioorganic & Medicinal Chemistry Letters. 12(7). 1103–1107. 14 indexed citations

Smyth, Mark S., Jack W. Rose, Mukund M. Mehrotra, et al.. (2001). Spirocyclic nonpeptide glycoprotein IIb–IIIa antagonists. Part 1: design of potent and specific 3,9-diazaspiro[5.5]undecanes. Bioorganic & Medicinal Chemistry Letters. 11(10). 1289–1292. 13 indexed citations

Pandey, Anjali, Deborah L. Volkots, Mark S. Smyth, et al.. (2001). Spirocyclic nonpeptide glycoprotein IIb–IIIa antagonists. Part 2: design of potent antagonists containing the 3-azaspiro[5.5]undec-9-yl template. Bioorganic & Medicinal Chemistry Letters. 11(10). 1293–1296. 11 indexed citations

Sall, Daniel J., Ann Arfsten, Jefferson R. McCowan, et al.. (1997). Use of Conformationally Restricted Benzamidines as Arginine Surrogates in the Design of Platelet GPIIb-IIIa Receptor Antagonists. Journal of Medicinal Chemistry. 40(18). 2843–2857. 15 indexed citations

Schultz, Arthur G., et al.. (1996). The First Asymmetric Total Syntheses of (+)-Lycorine and (+)-1-Deoxylycorine. Journal of the American Chemical Society. 118(26). 6210–6219. 56 indexed citations

Wu, Li, et al.. (1995). Why Is Phosphonodifluoromethyl Phenylalanine a More Potent Inhibitory Moiety Than Phosphonomethyl Phenylalanine Toward Protein-Tyrosine Phosphatases. Biochemical and Biophysical Research Communications. 216(3). 976–984. 99 indexed citations

10.

Kole, Hemanta K., et al.. (1995). Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases. Biochemical Journal. 311(3). 1025–1031. 56 indexed citations

11.

Burke, Terrence R., Motoyoshi Nomizu, Mark S. Smyth, et al.. (1994). Cyclic Peptide Inhibitors of Phosphatidylinositol 3-Kinase p85 SH2 Domain Binding. Biochemical and Biophysical Research Communications. 201(3). 1148–1153. 16 indexed citations

12.

Burke, Terrence R., Mark S. Smyth, Akihisa Otaka, et al.. (1994). Nonhydrolyzable Phosphotyrosyl Mimetics for the Preparation Of Phosphatase-Resistant SH2 Domain Inhibitors. Biochemistry. 33(21). 6490–6494. 171 indexed citations

13.

Roller, Peter P., Akira Otaka, Motoyoshi Nomizu, et al.. (1994). Norleucine as a replacement for methionine in phosphatase-resistant linear and cyclic peptides which bind to p85 SH2 domains. Bioorganic & Medicinal Chemistry Letters. 4(15). 1879–1882. 9 indexed citations

14.

Smyth, Mark S., Irena Štefanová, Ivan D. Horak, & Terrence R. Burke. (1993). Hydroxylated 2-(5'-salicyl)naphthalenes as protein-tyrosine kinase inhibitors. Journal of Medicinal Chemistry. 36(20). 3015–3020. 24 indexed citations

15.

Smyth, Mark S., Irena Štefanová, Frank Hartmann, et al.. (1993). Non-amine based analogs of lavendustin A as protein-tyrosine kinase inhibitors. Journal of Medicinal Chemistry. 36(20). 3010–3014. 32 indexed citations

16.

Schultz, Arthur G., Mark S. Smyth, & Fook S. Tham. (1991). Bimolecular cyclization of 2-fluoro-N-(hydroxyalkyl)benzamides. 2. Synthesis and structural characterization of 17- and 20-membered macrocycles. The Journal of Organic Chemistry. 56(24). 6952–6954. 6 indexed citations

17.

POSS, A. J. & Mark S. Smyth. (1989). The total synthesis of L-talonic lactone. Tetrahedron Letters. 30(39). 5201–5202. 4 indexed citations

18.

POSS, A. J. & Mark S. Smyth. (1988). The total synthesis of D-mycinose. Tetrahedron Letters. 29(45). 5723–5724. 5 indexed citations

19.

POSS, A. J. & Mark S. Smyth. (1987). The total synthesis of piptosidin. Tetrahedron Letters. 28(45). 5469–5472. 12 indexed citations

20.

POSS, A. J. & Mark S. Smyth. (1987). Diethyl 3-Bromopropene Phosphonate an Alkylative 8-Keto Phosphonate Equivalent. Synthetic Communications. 17(14). 1735–1740. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact